Non-alcoholic Fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes

We aimed to evaluate the effect of NAFLD on the risk of incident cardiovascular disease (CVD) and estimated glomerular filtration rate (eGFR)-based chronic kidney disease (CKD), and further test the joint effects and interactions between NAFLD status and individual metabolic element, as well as the total ‘ABCs’ metabolic goal achievement, on the CVD and CKD risk among 101,296 patients with prediabetes or diabetes from a prospective cohort study.

Source: Metabolism - Clinical and Experimental - September 9, 2021 Category: Biomedical Science Authors: Mian Li, Zhiyun Zhao, Guijun Qin, Li Chen, Jieli Lu, Yanan Huo, Lulu Chen, Tianshu Zeng, Min Xu, Yuhong Chen, Tiange Wang, Shuangyuan Wang, Yiping Xu, Lixin Shi, Xulei Tang, Qing Su, Xuefeng Yu, Li Yan, Qin Wan, Gang Chen, Zhengnan Gao, Guixia Wang, Feixi Source Type: research